These benefits, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the concept of concentrating on ACKR3 as a unique technique to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked disorders.Importantly, these receptors were be